IL46338A - Determination of serum creatinne - Google Patents
Determination of serum creatinneInfo
- Publication number
- IL46338A IL46338A IL46338A IL4633874A IL46338A IL 46338 A IL46338 A IL 46338A IL 46338 A IL46338 A IL 46338A IL 4633874 A IL4633874 A IL 4633874A IL 46338 A IL46338 A IL 46338A
- Authority
- IL
- Israel
- Prior art keywords
- sodium
- sulfate
- creatinine
- reagent
- detergent
- Prior art date
Links
- 210000002966 serum Anatomy 0.000 title abstract description 16
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 claims abstract description 72
- 238000000034 method Methods 0.000 claims abstract description 42
- 229940109239 creatinine Drugs 0.000 claims abstract description 36
- 239000003599 detergent Substances 0.000 claims abstract description 19
- 229940075930 picrate Drugs 0.000 claims abstract description 11
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 10
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 10
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims abstract description 9
- 239000004202 carbamide Substances 0.000 claims abstract description 9
- 230000015572 biosynthetic process Effects 0.000 claims abstract description 4
- 238000004737 colorimetric analysis Methods 0.000 claims abstract description 4
- 239000003153 chemical reaction reagent Substances 0.000 claims description 22
- 239000000243 solution Substances 0.000 claims description 21
- OXNIZHLAWKMVMX-UHFFFAOYSA-M picrate anion Chemical compound [O-]C1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-M 0.000 claims description 8
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 claims description 7
- 239000012530 fluid Substances 0.000 claims description 7
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 claims description 6
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 5
- 229910052700 potassium Inorganic materials 0.000 claims description 5
- 239000011591 potassium Substances 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 claims description 4
- 150000001335 aliphatic alkanes Chemical class 0.000 claims description 4
- 229910021538 borax Inorganic materials 0.000 claims description 4
- 229910052744 lithium Inorganic materials 0.000 claims description 4
- OXNIZHLAWKMVMX-UHFFFAOYSA-N picric acid Chemical class OC1=C([N+]([O-])=O)C=C([N+]([O-])=O)C=C1[N+]([O-])=O OXNIZHLAWKMVMX-UHFFFAOYSA-N 0.000 claims description 4
- 235000010339 sodium tetraborate Nutrition 0.000 claims description 4
- UPUIQOIQVMNQAP-UHFFFAOYSA-M sodium;tetradecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCOS([O-])(=O)=O UPUIQOIQVMNQAP-UHFFFAOYSA-M 0.000 claims description 4
- BSVBQGMMJUBVOD-UHFFFAOYSA-N trisodium borate Chemical compound [Na+].[Na+].[Na+].[O-]B([O-])[O-] BSVBQGMMJUBVOD-UHFFFAOYSA-N 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 3
- 239000011734 sodium Substances 0.000 claims description 3
- 239000012153 distilled water Substances 0.000 claims description 2
- CXPOFJRHCFPDRI-UHFFFAOYSA-N dodecylbenzene;sulfuric acid Chemical compound OS(O)(=O)=O.CCCCCCCCCCCCC1=CC=CC=C1 CXPOFJRHCFPDRI-UHFFFAOYSA-N 0.000 claims description 2
- 229940080236 sodium cetyl sulfate Drugs 0.000 claims description 2
- 229950005425 sodium myristyl sulfate Drugs 0.000 claims description 2
- 229940067741 sodium octyl sulfate Drugs 0.000 claims description 2
- 229960000776 sodium tetradecyl sulfate Drugs 0.000 claims description 2
- MWZFQMUXPSUDJQ-KVVVOXFISA-M sodium;[(z)-octadec-9-enyl] sulfate Chemical compound [Na+].CCCCCCCC\C=C/CCCCCCCCOS([O-])(=O)=O MWZFQMUXPSUDJQ-KVVVOXFISA-M 0.000 claims description 2
- HHURSJAUVYNJBT-UHFFFAOYSA-M sodium;heptadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCCOS([O-])(=O)=O HHURSJAUVYNJBT-UHFFFAOYSA-M 0.000 claims description 2
- GGHPAKFFUZUEKL-UHFFFAOYSA-M sodium;hexadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCOS([O-])(=O)=O GGHPAKFFUZUEKL-UHFFFAOYSA-M 0.000 claims description 2
- NWZBFJYXRGSRGD-UHFFFAOYSA-M sodium;octadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOS([O-])(=O)=O NWZBFJYXRGSRGD-UHFFFAOYSA-M 0.000 claims description 2
- WFRKJMRGXGWHBM-UHFFFAOYSA-M sodium;octyl sulfate Chemical compound [Na+].CCCCCCCCOS([O-])(=O)=O WFRKJMRGXGWHBM-UHFFFAOYSA-M 0.000 claims description 2
- HQCFDOOSGDZRII-UHFFFAOYSA-M sodium;tridecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCOS([O-])(=O)=O HQCFDOOSGDZRII-UHFFFAOYSA-M 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 230000031700 light absorption Effects 0.000 claims 6
- 102000007474 Multiprotein Complexes Human genes 0.000 claims 1
- 108010085220 Multiprotein Complexes Proteins 0.000 claims 1
- 239000007864 aqueous solution Substances 0.000 claims 1
- 239000013060 biological fluid Substances 0.000 claims 1
- 239000008366 buffered solution Substances 0.000 claims 1
- BITYAPCSNKJESK-UHFFFAOYSA-N potassiosodium Chemical compound [Na].[K] BITYAPCSNKJESK-UHFFFAOYSA-N 0.000 claims 1
- 239000012086 standard solution Substances 0.000 claims 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 claims 1
- 229910021653 sulphate ion Inorganic materials 0.000 claims 1
- 210000002700 urine Anatomy 0.000 abstract description 7
- 238000006243 chemical reaction Methods 0.000 abstract description 5
- 238000011156 evaluation Methods 0.000 abstract description 2
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000000706 filtrate Substances 0.000 description 6
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 6
- 238000007375 Jaffe assay Methods 0.000 description 4
- 230000000694 effects Effects 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- WMFOQBRAJBCJND-UHFFFAOYSA-M Lithium hydroxide Chemical compound [Li+].[OH-] WMFOQBRAJBCJND-UHFFFAOYSA-M 0.000 description 3
- 238000003745 diagnosis Methods 0.000 description 3
- 210000003734 kidney Anatomy 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 239000012224 working solution Substances 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000010828 elution Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 230000002452 interceptive effect Effects 0.000 description 2
- 238000005259 measurement Methods 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000001488 sodium phosphate Substances 0.000 description 2
- 229910000162 sodium phosphate Inorganic materials 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 230000002596 correlated effect Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000003412 degenerative effect Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000003544 deproteinization Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 208000003243 intestinal obstruction Diseases 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 201000008383 nephritis Diseases 0.000 description 1
- 238000000424 optical density measurement Methods 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- 239000008055 phosphate buffer solution Substances 0.000 description 1
- ONQDVAFWWYYXHM-UHFFFAOYSA-M potassium lauryl sulfate Chemical compound [K+].CCCCCCCCCCCCOS([O-])(=O)=O ONQDVAFWWYYXHM-UHFFFAOYSA-M 0.000 description 1
- 229940116985 potassium lauryl sulfate Drugs 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000007430 reference method Methods 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000011152 sodium sulphate Nutrition 0.000 description 1
- ABPBBOIVOUJALM-UHFFFAOYSA-M sodium;dodecyl sulfate;urea Chemical compound [Na+].NC(N)=O.CCCCCCCCCCCCOS([O-])(=O)=O ABPBBOIVOUJALM-UHFFFAOYSA-M 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 201000002327 urinary tract obstruction Diseases 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/70—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving creatine or creatinine
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/10—Composition for standardization, calibration, simulation, stabilization, preparation or preservation; processes of use in preparation for chemical testing
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/145555—Hetero-N
- Y10T436/147777—Plural nitrogen in the same ring [e.g., barbituates, creatinine, etc.]
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Cell Biology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US447864A US3894843A (en) | 1974-03-04 | 1974-03-04 | Determination of serum creatinine |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL46338A0 IL46338A0 (en) | 1975-03-13 |
| IL46338A true IL46338A (en) | 1977-10-31 |
Family
ID=23778053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL46338A IL46338A (en) | 1974-03-04 | 1974-12-25 | Determination of serum creatinne |
Country Status (12)
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4111657A (en) * | 1977-01-21 | 1978-09-05 | American Monitor Corporation | Creatinine assay and reagent system |
| US4529708A (en) * | 1983-04-07 | 1985-07-16 | American Monitor Corporation | Assay for the determination of creatinine |
| US4539295A (en) * | 1983-06-30 | 1985-09-03 | Beckman Instruments, Inc. | Binary kinetic assay method and apparatus |
| US4818703A (en) * | 1985-10-23 | 1989-04-04 | Pizzolante John M | Stabilized alkaline picrate reagent for jaffe creatinine determination |
| US4950611A (en) * | 1987-06-26 | 1990-08-21 | Beckman Instruments | Cold stable liquid creatinine reagent |
| CN101466875B (zh) * | 2006-06-12 | 2011-01-05 | 日矿金属株式会社 | 具有粗化处理面的轧制铜或铜合金箔以及该轧制铜或铜合金箔的粗化方法 |
| KR102205101B1 (ko) | 2014-02-28 | 2021-01-19 | 닛토덴코 가부시키가이샤 | 소변 검사 장치 및 정량적 소변 검사를 위한 건식 시약 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1648977A1 (de) * | 1967-07-20 | 1970-08-13 | Merck Anlagen Gmbh | Farbreagenz zur Bestimmung von Kreatinin |
| US3705013A (en) * | 1970-01-05 | 1972-12-05 | Xerox Corp | Analytical procedures and compositions therefor |
| US3682586A (en) * | 1971-03-10 | 1972-08-08 | Union Carbide Corp | Process for the determination of creatinine body fluids |
-
1974
- 1974-03-04 US US447864A patent/US3894843A/en not_active Expired - Lifetime
- 1974-12-18 NL NL7416476A patent/NL7416476A/xx unknown
- 1974-12-25 IL IL46338A patent/IL46338A/en unknown
-
1975
- 1975-01-08 BE BE6044885A patent/BE824205A/xx unknown
- 1975-01-13 ZA ZA00750224A patent/ZA75224B/xx unknown
- 1975-01-24 GB GB321475A patent/GB1445954A/en not_active Expired
- 1975-01-24 ES ES434127A patent/ES434127A1/es not_active Expired
- 1975-01-30 SE SE7501016A patent/SE7501016L/xx unknown
- 1975-01-30 FR FR7502948A patent/FR2263515A1/fr not_active Withdrawn
- 1975-01-31 JP JP50012630A patent/JPS50120897A/ja active Pending
- 1975-01-31 CH CH127875A patent/CH594245A5/xx not_active IP Right Cessation
- 1975-02-06 DE DE19752504994 patent/DE2504994A1/de active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| ES434127A1 (es) | 1977-03-01 |
| US3894843A (en) | 1975-07-15 |
| AU7596374A (en) | 1976-06-03 |
| IL46338A0 (en) | 1975-03-13 |
| SE7501016L (enrdf_load_stackoverflow) | 1975-09-05 |
| BE824205A (nl) | 1975-07-08 |
| ZA75224B (en) | 1976-08-25 |
| DE2504994A1 (de) | 1975-09-11 |
| CH594245A5 (enrdf_load_stackoverflow) | 1977-12-30 |
| FR2263515A1 (enrdf_load_stackoverflow) | 1975-10-03 |
| NL7416476A (nl) | 1975-09-08 |
| JPS50120897A (enrdf_load_stackoverflow) | 1975-09-22 |
| GB1445954A (en) | 1976-08-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Trivedi et al. | New enzymatic method for serum uric acid at 500 nm. | |
| Schade et al. | Bound iron and unsaturated iron-binding capacity of serum; rapid and reliable quantitative determination | |
| Iwata et al. | New micro-turbidimetric method for determination of protein in cerebrospinal fluid and urine. | |
| US3950226A (en) | Novel reagent and method for the determination of urea in biological fluids | |
| Walser | Determination of free magnesium ions in body fluids. Improved methods for free calcium ions, total calcium, and total magnesium | |
| Rej et al. | Interference by Tris buffer in the estimation of protein by the Lowry procedure | |
| EP0215170B1 (en) | Single color reading method for determining fructosamine | |
| CH642750A5 (it) | Procedimento per la rapida determinazione del ferro nel siero sanguigno e miscela per l'esecuzione del procedimento. | |
| WO1992011524A2 (en) | Reagent and methods for calcium determination | |
| US3894843A (en) | Determination of serum creatinine | |
| JPH0425000B2 (enrdf_load_stackoverflow) | ||
| CA1089338A (en) | Creatinine assay and reagent system | |
| JPWO2002086151A1 (ja) | 生体成分測定方法 | |
| Van Pilsum | Determination of creatinine and related guanidinium compounds | |
| US4529708A (en) | Assay for the determination of creatinine | |
| US5219760A (en) | Process for the determination of iron | |
| JPH07218511A (ja) | 鉄を測定する方法及びその試薬 | |
| US4211531A (en) | Colorimetric cholesterol assay | |
| Lawrie | The excretion of l (—)-tyrosine in urine | |
| US3778384A (en) | Diagnostic composition for the quantitative determination of glucose | |
| JPH0690207B2 (ja) | 血清中の鉄を定量する方法および複合試薬 | |
| CN105861631A (zh) | 血清中肌酐的紫外分光测定方法 | |
| Ujiie et al. | A new micromethod for colorimetric determination of zinc in serum | |
| Siltanen et al. | Determination of protein by the biuret reaction using cupric hydroxide suspension reagent | |
| Harrison et al. | Biomass measurements: protein |